Cipla, Boehringer Ingelheim join hands to co-market 3 oral anti-diabetic drugs in India

New Delhi, Jun 29: Pharma major Cipla and drug firm Boehringer Ingelheim India on Monday announced partnership to co-market three new oral anti-diabetic drugs in the country. The companies have entered into a partnership for co-marketing three new

from India News, India Breaking News, Latest news headlines in India - Oneindia News https://ift.tt/2VK3Lxt

• Tweet
• Share
• Share
• Share
• Share

About Admin MC3

This is dummy text. It is not meant to be read. Accordingly, it is difficult to figure out when to end it. But then, this is dummy text. It is not meant to be read. Period.

Related Post